Search

Now showing items 31-40 of 43

Treatment carryover impacts on effectiveness of intraocular pressure lowering agents, estimated by a discrete event simulation model.

Umuhire, D; Denis, Philippe; Le Pen, Claude; Berdeaux, Gilles (2008-01) Article accepté pour publication ou publié

Cost effectiveness of rituximab maintenance therapy in follicular lymphoma: long-term economic evaluation

Deconinck, Eric; Miadi-Fargier, Houda; Le Pen, Claude; Brice, Pauline (2010) Article accepté pour publication ou publié

Daily costs of prostaglandin analogues as monotherapy or in fixed combinations with timolol, in Denmark, Finland, Germany and Sweden

Bergström, Anders; Maurel, Frédérique; Le Pen, Claude; Lamure, Emilie; Kent, Michael; Bardoulat, Isabelle; Berdeaux, Gilles (2009) Article accepté pour publication ou publié

Impact of rheumatoid arthritis (ra) on working conditions and income

Le Pen, Claude; Bardoulat, Isabelle; Preiss, P.; Schadtler Law, L.; Fautrel, B.; Maurel, F. (2009) Article accepté pour publication ou publié

Is Orphan Designation a Driver of Orphan Drug Pricing?

Degrassat-Théas, Albane; Le Pen, Claude; Parent de Curzon, Olivier; Paubel, Pascal; Poisson, N.; Sinègre, Martine (2012) Article accepté pour publication ou publié

Cost-effectiveness of etanercept and efalizumab In the management of moderate and severe plaque psoriasis

Le Pen, Claude; Feneron, D.; Ortonne, J. P.; Daures, JP.; Ollivier, AL.; Thiriet, Catherine (2008) Article accepté pour publication ou publié

Psoriasis: an epidemiological evaluation of disease burden in 590 patients

Paul, Christophe; Le Pen, Claude; Fénéron, Delphine; Meyer, Nicolas; Bardoulat, Isabelle; Thiriet, Catherine; Camara, Catherine; Sid-Mohand, D.; Ortonne, J. P. (2010) Article accepté pour publication ou publié

To What Extent Can Biosimilars Compete with Brand Name Biologics? A EU-5 Granulocyte-Colony Stimulating Factors Markets Analysis

Fusier, Isabelle; Cordonnier, Anne-Laure; Paubel, Pascal; Bocquet, François; Le Pen, Claude (2013) Article accepté pour publication ou publié

Cost-effectiveness of using etanercept as first Line in severe and highly active rheumatoid Arthritis (ra)

Le Pen, Claude; Miadi-Fargier, Houda; Daures, JP.; Maurel, F.; Fautrel, B.; Maravic, M. (2008) Article accepté pour publication ou publié

A Long War Begins: Biosimilars Versus Patented Biologics – A Retrospective Analysis Of The Eu-5 And Japanese Erythropoetins Markets

Bocquet, François; Paubel, Pascal; Fusier, Isabelle; Cordonnier, Anne-Laure; Le Pen, Claude; Sinègre, Martine (2014) Article accepté pour publication ou publié